Malindang, Lyne Z.
HRN: 17-20-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2025
CEFUROXIME 500MG (TAB)
04/09/2025
04/16/2025
PO
500 Mg
Bid
S/p Perinorrhaphy
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes